Sabesan P, Lankappa S, Khalifa N, Krishnan V, Gandhi R, Palaniyappan L. Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls. World J Psychiatr 2015; 5(2): 170-181 [PMID: 26110119 DOI: 10.5498/wjp.v5.i2.170]
Corresponding Author of This Article
Dr. Lena Palaniyappan, Associate Professor in Translational Neuroimaging, Translational Neuroimaging for Mental Health, Division of Psychiatry and Applied Psychology, University of Nottingham, C-09, Institute of Mental Health, Triumph Road, Nottingham NG7 2TU, United Kingdom. lena.palaniyappan@nottingham.ac.uk
Research Domain of This Article
Psychiatry
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 2 Randomised Controlled Trials investigating antidepressant effect of transcranial magnetic stimulation in older subjects (mean age of sample > 60)
10 Hz; 110%MT; MRI-based target localisation of left DLPFC; 1200 pulses/session; 10 sessions; no. of pulses = 12000
30 (sham = 15)
Double blind RCT with look-alike sham coil in subjects > 50 yr age with vascular depression and failed at least one antidepressant; all patients medication-free for at least 4 d before TMS
Age inversely correlated with response; frontal volume positively correlated with response. Active treatment: 33.3% responders; sham: 6.7% responders. No drop-outs due to adverse events
10 Hz; 110%MT; MRI-based target localisation of left DLPFC; 1200 pulses/session; 15 sessions; no. of pulses = 18000
62 (sham = 29)
Double blind RCT with look-alike sham coil in subjects > 50 yr age with vascular depression and failed at least one antidepressant; all patients medication-free for at least 4 d before TMS
Active treatment: 39.4% responders; sham: 6.9% responders. Older subjects had better response for higher dose. No drop-outs due to adverse events
Table 3 Uncontrolled studies exploring the effect of age on the antidepressant effect of transcranial magnetic stimulation by recruiting older subjects (mean age of sample > 60) or undertaking analyses in subgroups with mean age > 60
10 Hz; 110%MT; left DLPFC; 500 pulses/session; 5 sessions; no. of pulses = 2500
50
Uncontrolled trial in patients > 18 yr attending a Mood Disorder Clinic (most referred for ECT)
Age associated with treatment response; < 65 (n = 28) responded better (56%) than > 65 group (n = 22; 23% response). Overall 42% responded after the 5 sessions
10 Hz; 100%MT; left DLPFC; 1600 pulses/session; 10 sessions; no. of pulses = 16000
11
Uncontrolled trial in patients age > 55 with vascular depression (first episode) and TRD but kept antidepressant free for 1 wk
5 out of 11 patients had clinically meaningful improvement in HDRS scores; response inversely related to frontal volume. No drop-outs due to adverse events
Variable parameters: LF (1 Hz, 1200 pulses/session, n = 14), HF (10 Hz, 1600 pulses/session n = 31); both LF and HF (n = 4); 80%-110%MT; right or left DLPFC
49
Uncontrolled trial that includes patients with TRD referred to 2 specialist mood disorder clinics; all except 3 medicated
24.7% mean reduction in HDRS scores; 18% responders; 1 dropout due to discomfort out of 49. (Note: This sample includes n = 20 from Abraham 2007)
1 Hz; 110%MT; right DLPFC; 420 pulses/session; 15 sessions.; no. of pulses = 6300
102
Uncontrolled trial in consecutively enrolled nonpsychotic subjects in a TMS clinic with TRD
Age inversely related to response especially in patients > 60 yr; overall 56.9% responded. 62.1% of < 60 (n = 66) and 47.2% of > 60 (n = 36) responded at 3 wk. 18.6% drop-outs due to intolerance
LF (1 Hz, 1200 pulses/session, n = 80), HF (10 Hz, 2000 pulses/session n = 13); 90%MT; right or left DLPFC; 15 sessions; no. of pulses = 18000
93
Uncontrolled trial in > 18 yr old subjects with TRD
Age not related to response; No difference between < 65 (n = 63; 53.3% responded) and > 65 age (n = 30; 46.7% responded) groups immediately and at 3 mo
Table 4 Summary of meta-analyses comparing transcranial magnetic stimulation and electroconvulsive therapy in depression
NNT = 6 favouring ECT for short-term response; at baseline, ECT samples had shorter illness duration and higher HAMD scores than rTMS samples. Age has no moderating effect on the differences
NNT = 7 for response; 6 for remission favouring ECT; No significant group difference when continuous change in HAMD scores is considered as outcome; In the absence of psychosis, rTMS as efficacious as ECT; Cognitive domains are better preserved after rTMS than ECT
OR = 0.55 for response and 0.49 for remission in favour of ECT; rTMS is better tolerated than ECT (OR = 0.70); rTMS > 1200 stimuli/d is as efficacious as ECT
Citation: Sabesan P, Lankappa S, Khalifa N, Krishnan V, Gandhi R, Palaniyappan L. Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls. World J Psychiatr 2015; 5(2): 170-181